How many institutional investors hold VIR?

3 tracked institutional investors disclosed a position in VIR (VIR BIOTECHNOLOGY INC) in their most recent 13F filing.

Who is the largest institutional holder of VIR?

Steve Cohen, Point72 Asset Management, holds the largest disclosed position in VIR, valued at $58M.

Did institutional ownership of VIR increase or decrease?

Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited VIR.

Where does this VIR ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

VIR — VIR BIOTECHNOLOGY INC

Name: VIR BIOTECHNOLOGY INC (VIR) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying VIR?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Net distribution · 0 buying vs 0 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

No tracked investor changed their VIR position last quarter. Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Contraction regime).

Supporting evidence

+3 tracked investors reported holding VIR at their latest filing
+Macro Health is 55/100 in a Contraction regime — historically acceptable for this sectorsource

Contradicting evidence — always shown

−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/17/2026.

About VIR BIOTECHNOLOGY INC (VIR)

VIR BIOTECHNOLOGY INC (VIR) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $58M. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in VIR

/100

Mixed Activity

Added / Increased0

Reduced0

Exited0

No recent activity recorded.

Crowded Trade Score™

How many top investors track VIR

/100

Emerging Interest

3investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

VIR Ownership Composition

How VIR BIOTECHNOLOGY INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Multi-Strategy / Quant

100% of tracked value

Institutions

tracked investors

Total Reported

$68.9M

combined 13F value

Multi-Strategy / Quant100.0%

Multi-Strategy / Quant(3)

100.0%

Tracked investors currently reporting VIR

1 tracked investor has since exited this position — listed separately below.

Investor	Firm	Shares	Market value	% of portfolio	As of
Steve Cohen	Point72 Asset Management	5.7M	$57.7M	0.06%	Jun 30, 2026
Ken Griffin	Citadel Advisors	1M	$10.6M	0.00%	Jun 30, 2026
Izzy Englander	Millennium Management	48K	$489K	0.00%	Jun 30, 2026

Steve CohenJun 30, 2026
Point72 Asset Management
Shares
5.7M
Value
$57.7M
% Portfolio
0.06%
Ken GriffinJun 30, 2026
Citadel Advisors
Shares
1M
Value
$10.6M
% Portfolio
0.00%
Izzy EnglanderJun 30, 2026
Millennium Management
Shares
48K
Value
$489K
% Portfolio
0.00%

Previously held VIR

These investors reported VIR in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

Investor	Firm	Last reported shares	Value then	Last held
Paul Tudor Jones	Tudor Investment Corp	73.5K	$658.6K	Mar 31, 2026

Recent activity

Investor	Action	Δ %	Current value	Filing date
No recent activity.

No recent activity.

Frequently asked questions

How many institutional investors hold VIR?: 3 tracked institutional investors disclosed a position in VIR (VIR BIOTECHNOLOGY INC) in their most recent 13F filing.
Who is the largest institutional holder of VIR?: Steve Cohen, Point72 Asset Management, holds the largest disclosed position in VIR, valued at $58M.
Did institutional ownership of VIR increase or decrease?: Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited VIR.
Where does this VIR ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.